Biomarkers of aging in HIV: inflammation and the microbiome.
Camilla TincatiEsther MerliniGiuseppe AnconaGiulia MarchettiPublished in: European geriatric medicine (2018)
Biomarkers need to be validated for their use in the management of HIV infection. Compounds which counteract microbial translocation, inflammation and dysbiosis have been investigated as alternative therapeutic strategies in viro-suppressed HIV-infected individuals, but appear to have limited efficacy, probably due to the multifactorial pathogenesis of non-infectious comorbidities in this setting.